U.S. COMPANY FILING
Elevance Health, Inc. — Form 10-Q filed 2026-04-22
Filing text preview
Elevance Health reported Q1 2026 total revenues of $50.18B, up 2.6% YoY, and net income of $1.76B, down 19.4%. The company initiated a 2026-2027 Operating Model Transformation Program, incurring $129M in costs. Net losses on financial instruments were $78M, primarily from other investments. Diluted EPS was $8.00, down from $9.61. Quarterly dividend maintained at $1.72 per share.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record